Company / Current Liabilities
Bristol Myers Squibb Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$23.4B
FY2025
5-year range
$21.9B / $23.8B
FY2021-FY2025
Trend
-1.5%
vs FY2024
Sector context
#7 of 213
Health Care
What the data says
Among 213 Health Care companies, Bristol Myers Squibb is in the bottom 3% for current liabilities. Increased from $22.3B to $23.4B over the past 2 years.
Based on SEC 10-K filings.
$23.4B in FY2025 with a 5-year CAGR of +4.2%. Top quartile in the Health Care sector.
Increased from $22.3B to $23.4B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +2.3%
- 5-Year CAGR
- +4.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 213This company $23.4B Sector average $1.6B
▼
+1374.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.2%, indicating consistent growth.
- In FY2025, current liabilities decreased 1.5% year-over-year.
- Ranks #7 out of 213 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $23.4B | -1.5% |
| FY2024 | $23.8B | +6.8% |
| FY2023 | $22.3B | +1.7% |
| FY2022 | $21.9B | +0.1% |
| FY2021 | $21.9B | +14.6% |
| FY2020 | $19.1B | +4.2% |
| FY2019 | $18.3B | +71.8% |
| FY2018 | $10.7B | +11.4% |
| FY2017 | $9.6B | +8.2% |
| FY2016 | $8.8B | +10.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026